Results 111 to 120 of about 98,529 (269)

Obesity and polycystic ovary syndrome : implications for pathogenesis and novel management strategies [PDF]

, 2019
Polycystic ovary syndrome (PCOS) is a common female condition typified by reproductive, hyperandrogenic, and metabolic features. Polycystic ovary syndrome is a genetic condition, exacerbated by obesity.
Barber, Thomas M., Franks, Stephen, Hanson, Petra, Weickert, Martin O.   +3 more
core   +2 more sources

Weekly Subcutaneous VK2735, a GIP/GLP‐1 Receptor Dual Agonist, for Weight Management: Phase 2, Randomized, 13‐Week VENTURE Study

Obesity, EarlyView.
Four doses of VK2735 and a placebo group were included in the VENTURE study. Adults who were overweight or had obesity had significant weight loss when taking any dose of VK2735 for 13 weeks. More people lost at least 10% of their body weight as the dose increased.
Harold E. Bays, Phillip Toth, Naim Alkhouri, John Pullman, Bradley Freilich, Joel Neutel, Summer Ji, Scott Stubbe, Parke Hedges, Brian Lian   +9 more
wiley   +1 more source

Metformin in polycystic ovary syndrome: systematic review and meta-analysis [PDF]

, 2003
The original publication may be found at www.bmj.comObjective To assess the effectiveness of metformin in improving clinical and biochemical features of polycystic ovary syndrome. Design Systematic review and meta-analysis.
Flight, I., Lord, J., Norman, R.
core   +1 more source

Advancing Extracellular Vesicle Research: A Review of Systems Biology and Multiomics Perspectives

PROTEOMICS, EarlyView.
ABSTRACT Extracellular vesicles (EVs) are membrane‐bound vesicles secreted by various cell types into the extracellular space and play a role in intercellular communication. Their molecular cargo varies depending on the cell of origin and its functional state.
Gloria Kemunto, Samaneh Ghadami, Kristen Dellinger   +2 more
wiley   +1 more source

Obesity and Polycystic Ovary Syndrome

Journal of Obesity & Metabolic Syndrome
The core pathophysiology of polycystic ovary syndrome involves an overproduction of androgens primarily originating from ovarian thecal cells. Two major external triggers promote androgen overproduction in the ovaries: the increased secretion of ...
Jin Ju Kim
doaj   +1 more source

A negative correlation of thyroid stimulating hormone with anti_mullerian hormone and with luteinizing hormone in polycystic ovary syndrome and/or hypothyroid women

Middle East Fertility Society Journal, 2018
Background: Using anti_mullerian hormone (AMH) for Polycystic Ovary Syndrome diagnosis is not always constant. Thyroid dysfunction may effect on AMH levels.
Samal Hakeem Kareem AL-Jaff
doaj   +1 more source

The Polycystic Ovary Morphology-Polycystic Ovary Syndrome Spectrum [PDF]

Journal of Pediatric and Adolescent Gynecology, 2015
Polycystic ovary syndrome (PCOS) is the most common cause of chronic hyperandrogenic anovulation. Two-thirds of PCOS patients have functionally typical PCOS, with typical functional ovarian hyperandrogenism manifest as 17-hydroxyprogesterone hyper-responsiveness to gonadotropin stimulation.
openaire   +2 more sources

Differences in female athlete triad risk factors between Japanese and American female runners: A comparative study

PM&R, EarlyView.
Abstract Background Differences in female athlete triad risk factors between runners from Japan and the United States have not been explored. Objective To compare the prevalence of Triad risk factors and Triad components between female Japanese and American distance runners. Design Observational, cross‐sectional.
Ana Carla C. Salamunes, Natsue Koikawa, Nancy I. Williams, Kristen J. Koltun, Maha L. Vijaya Krishnan, Yuko Sakurama, Takao Matsuda, Shihoko Suzuki, Yuji Takazawa, Mary Jane De Souza   +9 more
wiley   +1 more source

Ethnic-specific association of LEPR rs1137101 polymorphism with polycystic ovary syndrome risk: A meta-analysis and bioinformatics study [PDF]

Cellular, Molecular and Biomedical Reports
Polycystic ovary syndrome is a common endocrine disorder with complex genetic and metabolic factors. Polymorphisms in the leptin receptor gene may alter the risk of polycystic ovary syndrome.
Mohammad Karimian, Leila Vafadar Ghasemi
doaj   +1 more source

Polycystic ovary syndrome [PDF]

Human Reproduction, 1996
R, Homburg, L C, Giudice, R J, Chang
openaire   +2 more sources